1-BENZYL-4-(1-BENZYLPYRIDIN-1-IUM-4-YL)PYRIDIN-1-IUM DICHLORIDE, 95%, 10g

3-Tolualdehyde, 97.0%, 25g

3-Bromo-5-fluoropicolinic acid, 95.0%, 100g

1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 1g

tert-Butyl 4-(2-(benzyl(tert-butoxycarbonyl)amino)-2-oxo-1-(2-phenyl-1H-benzo[d]imidazol-1-yl)ethyl)piperidine-1-carboxylate, 95%, 100mg

(3-Nitrophenyl)-N,N-dimethylmethanamine, 98%, 25g

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 100mg

5-(2-Methylsulfanyl-ethyl)-imidazolidine-2,4-dione, 99.0%, 1g

ROTI®Quant, 50 ml, 200 assays (cuvettes)

tert-Butyl 6-(2-ethoxy-2-oxoethyl)-2-azaspiro[3.3]heptane-2-carboxylate, 97%, 1g

2-Oxa-6-azaspiro[3.4]octane oxalate, 97%, 250mg

N-BOC-L-Prolinal, 96.0%, 1g

2-Chloro-4-hydroxypyridine, 95.0%, 25g